Wei Xu, Ph.D., and Hao Zeng, graduate student, at McArdle Laboratory for Cancer Research, UW-Madison, have identified a key component of endocrine-therapy resistance in breast cancer, a finding that could lead to the development of new treatment approaches for the most common subtype of the disease.